Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
High Growth Tech Stocks to Watch in November 2024

In This Article:

Over the last 7 days, the United States market has dropped by 1.0%, yet in the longer term, it has risen by 30% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks involves evaluating companies that demonstrate robust innovation and adaptability to capitalize on emerging opportunities.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Super Micro Computer

23.83%

24.32%

★★★★★★

Sarepta Therapeutics

23.90%

42.65%

★★★★★★

Clene

78.50%

60.70%

★★★★★★

TG Therapeutics

34.66%

56.48%

★★★★★★

Alkami Technology

21.89%

98.60%

★★★★★★

Travere Therapeutics

31.70%

72.51%

★★★★★★

Alnylam Pharmaceuticals

22.45%

70.66%

★★★★★★

Blueprint Medicines

25.47%

68.62%

★★★★★★

Seagen

22.57%

71.80%

★★★★★★

ImmunoGen

26.00%

45.85%

★★★★★★

Click here to see the full list of 249 stocks from our US High Growth Tech and AI Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Geron

Simply Wall St Growth Rating: ★★★★★☆

Overview: Geron Corporation is a late-stage clinical biopharmaceutical company dedicated to developing and commercializing therapeutics for myeloid hematologic malignancies, with a market capitalization of approximately $2.29 billion.

Operations: The company generates revenue primarily from the development of therapeutic products for oncology, totaling $29.48 million.

Geron's trajectory in high-growth tech is marked by significant R&D initiatives and strategic leadership appointments, notably with Dr. Joseph Eid's recent role as EVP of R&D, enhancing its focus on innovative medical strategies for its key product, RYTELO™. The firm’s commitment to growth is underscored by a substantial increase in revenue from $0.164 million to $28.27 million year-over-year and a reduction in net loss from $44.81 million to $26.45 million, reflecting a robust 51.8% revenue growth rate and an anticipated earnings surge of 72.4%. Additionally, Geron secured a senior secured term loan facility up to $250 million, ensuring ample capital for future endeavors and underscoring its aggressive pursuit of breakthroughs in myeloid hematologic malignancies with the novel telomerase inhibitor imetelstat.

NasdaqGS:GERN Revenue and Expenses Breakdown as at Nov 2024
NasdaqGS:GERN Revenue and Expenses Breakdown as at Nov 2024

Crane NXT

Simply Wall St Growth Rating: ★★★★★☆

Overview: Crane NXT, Co. is an industrial technology company that offers solutions for securing, detecting, and authenticating critical assets, with a market capitalization of $3.23 billion.